Trump-Era FDA Issues Warning Letters to Chicago Company Over Chest Binder Sales

The U.S. Food and Drug Administration (FDA), under policies stemming from the Trump administration, has sent warning letters to a Chicago-based company involved in the sale of chest binders, according to reports.

The FDA raised concerns that the products may be marketed or distributed in ways that violate federal regulations, including potential issues related to medical claims, safety standards, and consumer protection laws. Chest binders, which are compression garments, have drawn increased regulatory attention due to possible health risks when used improperly.

In its warning, the FDA reportedly instructed the company to address compliance issues promptly or face possible enforcement actions, which could include fines, product seizures, or injunctions.

The company has not yet issued a public response, and it remains unclear whether it will modify its products or marketing practices to meet FDA requirements.

The move has sparked debate online, with supporters citing the need for consumer safety and regulatory oversight, while critics argue it could impact access to products relied upon by certain communities.

Further details are expected as the situation develops.

—
Stay with 90livenews.com for breaking U.S. news and regulatory updates.